Form 4: Chelsea Clinton Reports Acquisition of Clover Health Investments Stock

Chelsea Clinton, a director of Clover Health Investments, reported the acquisition of 60,975 shares of Class A common stock on January 6, 2025, as part of a restricted stock unit award.

Summary

• Chelsea Clinton, a director of Clover Health Investments, Corp., filed a Form 4 on January 8, 2025, reporting a transaction that occurred on January 6, 2025.
• The transaction involved the acquisition of 60,975 shares of Class A common stock through a time-based restricted stock unit (RSU) award.
• These RSUs will vest fully on January 6, 2026, contingent upon Ms. Clinton's continued service on the company's Board of Directors.
• Following the reported transaction, Ms. Clinton beneficially owns 602,814 shares of Class A common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to stock ownership. The acquisition of shares by a director can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued service as a member of the Company's Board of Directors through January 6, 2026.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence.

Key Dates